Story perspectives

Cu(ATSM) Clears Amyloid, Boosts Memory — 24% Pump Rise

6/19/2026

Summary

Story summary

Cu(ATSM) cleared amyloid plaques and improved memory in a pre-clinical Alzheimer’s study.
Monash University researchers observed lower amyloid levels and enhanced spatial learning in APP/PS1 mice treated with Cu(ATSM).
The treatment increased blood-brain-barrier P-glycoprotein pump activity by 24.1 percent, linking pump restoration to toxin reduction.
Cu(ATSM) has already cleared safety testing for Parkinson’s and ALS, enabling a faster move to human Alzheimer’s trials.

1 of 1

Story summary

Cu(ATSM) cleared amyloid plaques and improved memory in a pre-clinical Alzheimer’s study.
Monash University researchers observed lower amyloid levels and enhanced spatial learning in APP/PS1 mice treated with Cu(ATSM).
The treatment increased blood-brain-barrier P-glycoprotein pump activity by 24.1 percent, linking pump restoration to toxin reduction.
Cu(ATSM) has already cleared safety testing for Parkinson’s and ALS, enabling a faster move to human Alzheimer’s trials.